← Leaderboards
Lydie Trautmann
Vgti Florida
$6,280,352
Attributed
$11,107,191
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,107,191 · 5
By mechanism
R01$10,656,844 · 4
R21$450,347 · 1
Top collaborators
- Afamefuna Okoye7 shared
- Lishomwa C Ndhlovu4 shared
- Serena S Spudich4 shared
- Nicolas Chomont2 shared
Others in their field
Top investigators on “Cd8b1 Gene”
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Rama Rao Amara · Emory University$47,095,662
- Rafi Ahmed · Emory University$42,649,225
- Louis J. Picker · Oregon Health And Science University$26,538,123
- Eric Hunter · University Of Alabama At Birmingham$26,385,296
- Arlene H Sharpe · Harvard Medical School$25,020,892
Research focus
Cd8b1 GeneMediatingHiv InfectionsAntiretroviral TherapyViralInfectionAcuteInterruptionCd4 Positive T LymphocytesInflammationBaseLeadChronicT Cell ResponseImmuneCellsT-LymphocyteMemoryParticipantPlasmaCell PhysiologyGene ExpressionB-LymphocytesCell Killing
Grant awards (17)
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$974,060
R01 · FY2025 · MH · contact PI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$975,768
R01 · FY2024 · MH · contact PI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$974,407
R01 · FY2023 · MH · contact PI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$1,165,864
R01 · FY2022 · MH · contact PI
Targeting the HIV/SIV reservoir at time of ART initiation$696,598
R01 · FY2021 · AI
Targeting the HIV/SIV reservoir at time of ART initiation$687,893
R01 · FY2020 · AI
Critical Role of Cytotoxic T Cells in HIV Neuropathogenesis$608,868
R01 · FY2019 · MH · contact PI
Critical Role of Cytotoxic T Cells in HIV Neuropathogenesis$552,494
R01 · FY2018 · MH · contact PI
Preservation of adaptive immunity leads to HIV control upon treatment cessation.$688,050
R01 · FY2017 · AI · contact PI
Critical Role of Cytotoxic T Cells in HIV Neuropathogenesis$561,141
R01 · FY2017 · MH · contact PI
Preservation of adaptive immunity leads to HIV control upon treatment cessation.$692,401
R01 · FY2016 · AI · contact PI
Critical Role of Cytotoxic T Cells in HIV Neuropathogenesis$559,921
R01 · FY2016 · MH · contact PI
Preservation of adaptive immunity leads to HIV control upon treatment cessation.$511,648
R01 · FY2015 · AI · contact PI
Purging the latent HIV reservoir at ART inititation: A new eradication strategy$248,850
R21 · FY2015 · AI · contact PI
Preservation of adaptive immunity leads to HIV control upon treatment cessation.$148,740
R01 · FY2015 · AI · contact PI
Preservation of adaptive immunity leads to HIV control upon treatment cessation.$858,991
R01 · FY2014 · AI · contact PI
Purging the latent HIV reservoir at ART initiation: A new eradication strategy$201,497
R21 · FY2014 · AI · contact PI